FFRangio System vs syngo.CT CaScoring
AI Verdict
Choose FFRangio System if…
Choose the CathWorks FFRangio System if you are an interventional cardiologist seeking real-time, wire-free functional assessment of coronary artery disease during a cardiac catheterization. This tool is ideal for optimizing and confirming percutaneous coronary intervention (PCI) decisions by providing accurate multi-vessel FFR results and insights into lesion impact without the need for invasive pressure wires or drugs.
View FFRangio System →Choose syngo.CT CaScoring if…
Choose syngo.CT CaScoring if you are a radiologist or cardiologist focused on non-invasive cardiovascular risk assessment and early detection of coronary artery disease. This AI-powered software is best suited for quantifying and visualizing calcified coronary lesions from CT scans, providing Agatston scores and plaque burden analysis to stratify patient risk and inform preventive strategies.
View syngo.CT CaScoring →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FFRangio System | syngo.CT CaScoring |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Contact for pricing |
| Deployment | SaaS, on-prem, hybrid | Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FFRangio SystemThe FFRangio System (Tool A) emphasizes an intuitive user interface and seamless integration with cath lab equipment for real-time, in-procedure guidance, which is crucial for immediate clinical impact and workflow efficiency. While syngo.CT CaScoring (Tool B) offers quick quantification and visualization, its role as a post-processing application suggests a different, less immediate interaction model.
Clinical Value
FFRangio SystemThe FFRangio System (Tool A) offers wire-free and drug-free 3D FFR guidance, directly impacting interventional decision-making during PCI and eliminating the need for invasive pressure wires. This represents a significant advancement in reducing invasiveness and optimizing treatment. syngo.CT CaScoring (Tool B), while valuable for cardiovascular risk assessment, primarily enhances an existing diagnostic method.
Pricing & Value
syngo.CT CaScoringsyngo.CT CaScoring (Tool B) offers more pricing transparency by having a historical list price and indicating a one-time license purchase model, even if current pricing requires contacting the vendor. The FFRangio System (Tool A) only states 'contact for pricing' without any further details, offering less insight into its cost structure.
Enterprise Readiness
syngo.CT CaScoringSiemens Medical Solutions USA (Tool B) is a major healthcare technology provider with a long history of integrating solutions into large hospital systems, and its deployment on the multi-user syngo.via client/server platform demonstrates robust enterprise capabilities. While CathWorks (Tool A) is ISO 27001 certified, Siemens' broader established infrastructure and platform integration suggest superior enterprise readiness.
Innovation
FFRangio SystemThe FFRangio System (Tool A) represents a more disruptive innovation by providing wire-free and drug-free 3D FFR guidance, offering a non-invasive alternative to a previously invasive procedure. syngo.CT CaScoring (Tool B) enhances an existing diagnostic method (coronary calcium scoring) with AI-powered quantification, which is an improvement rather than a fundamental shift in methodology.
Support & Docs
syngo.CT CaScoringSiemens Healthineers (Tool B) offers extensive and well-documented support services, including 24/7 online, on-site, and phone support, along with comprehensive educational resources and a document library. CathWorks (Tool A) provides Instructions For Use and a video library, but its overall support infrastructure appears less comprehensive and explicitly detailed compared to Siemens.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FFRangio System | syngo.CT CaScoring |
|---|---|---|
| Primary Purpose | Delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease. | AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation. |
| Company | CathWorks | Siemens Medical Solutions USA |
| Input Data Source | C-arm angiography systems | CT scans |
| Key Measurement/Analysis Output | Real-time FFRangio values at every point on the coronary tree, simulated pullback curve, lesion impact, integrated sizing tool for non-invasive lesion measurements. | Quick quantification and accurate visualization of calcified coronary lesions, Agatston Score, volume, calcium mass, plaque burden, 'Coronary Age'. |
| Elimination of Invasive Components | Eliminates the need for invasive pressure wires, drugs, or a guide catheter. | Not specified |
| Core AI Application | Aids in quick angiogram analysis. | AI-powered image analysis for quick quantification and accurate visualization of calcified coronary lesions. |
| Target Medical Specialties | Cardiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring FFRangio System and syngo.CT CaScoring.